Familial Hypercholesterolemia - Screening

Screening

Although case finding among family members of patients with known FH is a cost-effective approach, other strategies such as universal screening at the age of 16 have also been suggested. The latter approach may however be less cost-effective in the short term. Screening at an age lower than 16 would lead to an unacceptably high rate of false positives.